OrfoNeuro ApS: Financial statements 2025
CVR: 37768901
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545. The solvency ratio was 11.7%.
- Gross Profit
- DKK -267,558
- Profit/Loss
- DKK -289,729
- Equity
- DKK 9,545
- Total Assets
- DKK 81,883
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -268K | -290K | 10K | 0 |
| 2024 | - | -199K | -243K | -1.1M | 0 |
| 2023 | - | -148K | -208K | -808K | 0 |
| 2022 | - | -90K | -95K | -599K | 0 |
| 2021 | - | -79K | -88K | -504K | 0 |
Official annual report
How creditworthy is OrfoNeuro ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 5, 2025, Per Toft Valstorp has joined the board of directors of OrfoNeuro ApS.
As of December 5, 2025, Ulrik Spork has joined the board of directors of OrfoNeuro ApS.
As of December 5, 2025, Jens Morten Fogh has joined the board of directors of OrfoNeuro ApS.
As of July 30, 2025, VALSTORP & COMPANY ApS is registered as an owner of OrfoNeuro ApS with an ownership share of 20%.
As of July 30, 2025, is registered as an owner of OrfoNeuro ApS with an ownership share of 5%.
As of July 7, 2025, JIMKKS Holding ApS is registered as an owner of OrfoNeuro ApS with an ownership share of 66%.
OrfoNeuro ApS has published its annual report for 2024. Gross profit came to DKK -199,417, and the net result was DKK -242,569.
As of June 2, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of OrfoNeuro ApS.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.